GovChime
Notice ID: c461995476b74d538cde1ae74d775cc6Presolicitation

Olink Target 96 Inflammation Analysis Service

Archived on August 15, 2021. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
10:00 AM UTC−04:00
Posted
July 27, 2021
Notice type
Presolicitation
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NIH, NIEHS, OD OM OA OFC ACQUISITIO
Place of performance
Durham, NC, 27709
Last updated
Dec 4, 2025

Identifiers

Solicitation number
VS6038346
Notice ID
c461995476b74d538cde1ae74d775cc6

Description

This contract action is for the acquisition of service for which the Government intends to solicit and negotiate with only one source under the authority of Federal Acquisition Regulation (FAR) Subpart 13.106-1(b)(1). The National Institute of Environmental Health Science (NIEHS), Office of Acquisitions (OA) intends to award a single source purchase order to Onlink Proteomics AB, Uppsala Science Park, Uppsala, SE-751 83, Sweden, for the acquisition of Inflammation Analysis/Study Services. This analysis/study service is required to quantify a large number of proteins in plasma samples collected from participants in pregnancy. The Epidemiology Branch, DIR, at the NIEHS require a proteomic technology platform that can quantify proteins closely related to inflammatory processes across a large number of participant samples. The primary delivery will be the generation of data that includes relative concentration levels of proteins across plasma samples, including rigorous quality control standard to ensure data accuracy, precision, and reproducibility. The applicable North American Industry Classification System (NAICS) Code for this acquisition is 325413, In-Vitro Diagnostic Substance Manufacturing . The Business Size Standard is 1250. This requirement is set aside for small businesses only. 1. #91301- Onlink Target 96 Inflammation Analysis Service (QTY 1500) It has been determined that Onlink Proteomics AB, is the only known responsible source capable of providing the required service agreement and no other service will satisfy the agency's requirements. NIEHS will solicit and negotiate directly with Onlink Proteromics AB, and no solicitation will be issued. This notice of intent is not a request for competitive proposals or quotations; however, all responsible sources may submit a capability statement which shall be considered by the agency. Offerors must have an active registration in SAM.GOV (SAM) www.sam.gov. A determination by the Government not to compete this proposed requirement based on responses to this notice is solely within the discretion of the Government. Interested parties must express their interest and must be submitted in writing via email to Valarie K. Sims at sims3@niehs.nih.gov and are due by 10:00 AM, July 31, 2021. No faxed documents will be accepted. If no responsive statements are received by the due date, an award will be made to Onlink Proteomics AB.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:VS6038346
  1. Pre-Solicitation

Formal solicitation typically follows within 30–60 days. (estimate)

  1. Pre-SolicitationCurrentJul 27, 2021

    Olink Target 96 Inflammation Analysis Service

    Notice c461995476b74d538cde1ae74d775cc6 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Phadia 250 Reagent and Consumables
-AwardedOpen
Please see attached Combined Synopsis/Solicitation. See attached estimated quantities and Questions and Answers.
-Combined Synopsis11/18/2026
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00027. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Integrated DNA Technologies, Inc. (IDT), 1710 Commercial Park, Coralville, IA 52241, for custom-designed ArcherDX VariantPlex Next-Generation Sequencing (NGS) target-enrichment library preparation kits. Integrated DNA Technologies, Inc. is the sole owner, manufacturer, and distributor of the proprietary ArcherDX VariantPlex Anchored Multiplex PCR (AMP) chemistry, which has been utilized by the NHLBI Hematology Branch since 2019 to perform error-correcting sequencing (ECS) and is required to maintain scientific continuity, prevent technical batch effects across longitudinal patient cohorts, and ensure compatibility with the laboratory¿s established Archer Analysis bioinformatics pipeline. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing) and the small business size standard is 1,250 employees. This requirement is not set aside for small business.
-Combined Synopsis11/05/2026
See attached Sources Sought Notice.
-Market Research10/28/2026
Amendment 5 is being issued to re-open the solicitation and proceed with source selection activities. Reinstate Jennifer Gartzke as the point of contact. The attached SF30 contains additional information.
-Solicitation02/15/2026

Additional Details

Solicitation Number

VS6038346

Archive Date

Aug 15, 2021

Office Address

RESEARCH TRIANGLE PAR, NC, 27709